SFD S.A. (WSE:SFD)

Revenue by Segment

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Wholesale - Drugs	440.94M	355.51M	343.39M	325.35M	245.39M
Wholesale - Drugs Growth	24.03%	3.53%	5.55%	32.59%	24.61%
Total	440.94M	355.51M	343.39M	325.35M	245.39M
Total Growth	24.03%	3.53%	5.55%	32.59%	24.61%

Revenue by Geography

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Poland	389.60M	310.81M	291.04M	283.27M	214.36M
Poland Growth	25.35%	6.79%	2.74%	32.15%	23.98%
Export	51.35M	44.70M	52.36M	42.08M	31.03M
Export Growth	14.86%	-14.62%	24.43%	35.60%	29.20%
Total	440.94M	355.51M	343.39M	325.35M	245.39M
Total Growth	24.03%	3.53%	5.55%	32.59%	24.61%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 26, 2026

Data Sources Report a data error